Expand AGEN Menu

AGEN Stock Summary and Trading Ideas (Agenus | NASDAQ:AGEN)

Charts for Today's Stock Price and Implied Volatility in Agenus


Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for AGEN by Theoretical Edge and Win Rates


Trading Statistics

Key Ratios

Agenus (AGEN) Frequently Asked Questions

What does Agenus do?

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

What symbol and exchange does Agenus stock trade?

Agenus trades on the NASDAQ stock market under the symbol AGEN.

What is Agenus stock price doing today?

As of June 21, 2024, AGEN stock price climbed to $14.56 with 578,488 million shares trading.

What is Agenus's Beta?

AGEN has a beta of 3.31, meaning it tends to be more sensitive to market movements. AGEN has a correlation of 0.11 to the broad based SPY ETF.

How much is Agenus worth?

AGEN has a market cap of $305.75 million. This is considered a Small Cap stock.

How much money does Agenus make?

Last quarter Agenus reported $28 million in Revenue and -$3.04 earnings per share. This fell short of revenue expectation by $-11 million and missed earnings estimates by -$.21.

What is the highest and lowest price Agenus traded in the last 3 year period?

In the last 3 years, AGEN stock traded as high as $135.80 and as low as $4.78.

What are the top ETFs holding Agenus?

The top ETF exchange traded funds that AGEN belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

Is Agenus (AGEN) a good investment?

AGEN has underperformed the market in the last year with a price return of -60.4% while the SPY ETF gained +26.8%. However, in the short term, AGEN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +29.5% vs +4.6% return in SPY. But in the last 2 weeks, AGEN shares have been beat by the market, returning -12.3% compared to an SPY return of +2.3%.

What is the support and resistance for Agenus (AGEN) stock price?

AGEN support price is $12.66 and resistance is $14.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGEN stock will trade within this expected range on the day.